C-CAR039
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for C-CAR039, covering 2025-05-23 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of C-CAR039 in Subjects With Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma [Phase 1]